Moody Aldrich Partners LLC Viridian Therapeutics, Inc.\De Transaction History

Moody Aldrich Partners LLC

  • $503 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 28, 2023
SELL
$22.57 - $29.67 $947,375 - $1.25 Million
-41,975 Reduced 42.22%
57,451 $1.37 Million
Q1 2023

Apr 27, 2023
BUY
$25.04 - $37.6 $1.01 Million - $1.52 Million
40,515 Added 68.77%
99,426 $2.53 Million
Q4 2022

Jan 23, 2023
BUY
$18.78 - $29.74 $1.11 Million - $1.75 Million
58,911 New
58,911 $0

Others Institutions Holding VRDN

# of Institutions
179
Shares Held
76.8M
Call Options Held
581K
Put Options Held
439K
View Full List

About Viridian Therapeutics, Inc.\DE

VRDN Quotes by TradingView
  • Ticker VRDN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,888,900
  • Market Cap $806M
  • Description
  • Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients suffering from serious diseases. It develops VRDN-001, a humanized monoclonal anti-IGF-1R antibody that is in Phase 1/2 clinical trial for the treatment of thyroid eye disease (TED); VRDN-002, an IGF-1R antibody, which is in Phase 1 clinical trial; and VRDN-00...
More about VRDN
Track This Portfolio

Track Moody Aldrich Partners LLC Portfolio

Follow Moody Aldrich Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Moody Aldrich Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Moody Aldrich Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email